New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2014
07:41 EDTCNC, AETAetna Centene to get boost from prior period development, says Wells Fargo
After reviewing managed care companies' reserves, Wells Fargo believes that Aetna (AET) and Centene (CNC) could get a "fairly significant" EPS boost in 2014 from higher favorable prior period development, or PPD. At the very least, higher PPD should cushion Aetna and Centene from higher than expected medical costs, added the firm, which keeps Outperform ratings on both stocks.
News For AET;CNC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 27, 2015
15:04 EDTAET, CNCNotable companies reporting before tomorrow's open
Subscribe for More Information
13:27 EDTAETAetna technical comments ahead of earnings
Subscribe for More Information
13:15 EDTAETEarnings Watch: Aetna to report Q1 results amid continued membership growth
Aetna (AET) is scheduled to report first quarter earnings before the market open on Tuesday, April 28 with a conference call scheduled for 8:00 am ET. Aetna operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. EXPECTATIONS: Analysts are looking for earnings per share of $1.95 on revenue of $15.46B, according to First Call. The consensus range for EPS is $1.87-$2.13 on revenue of $15.08B-$16.0B. LAST QUARTER: Aetna reported fourth quarter EPS of $1.22, which was in-line with consensus estimates, on revenue of $14.77B against estimates of $14.6B. The company raised its fiscal 2015 EPS view to at least $7.00, against consensus estimates at the time of $7.16. "Aetna achieved record annual operating revenue and operating earnings in 2014, and delivered full-year operating earnings per share at the high end of our most recent projection," said Aetna chairman and CEO Mark Bertolini. "Our 2014 operating earnings-per-share results represent an increase of more than 7% over 2013 and a compound annualized growth rate of 15% since 2010. We also ended the year serving more than 23.5M medical members, an increase of approximately 1.4M members from 2013." STREET RESEARCH: On March 19, Sterne Agee upgraded Aetna to Buy from Neutral. The firm says that the company is the best-positioned name within the large-cap health plan space, a defensive sector that has little exposure to Europe and reasonable growth prospects, according to the firm. On March 12, Argus increased its price target on Aetna to $115 from $103 after Aetna's Q4 membership growth exceeded its prior targets. The firm said it thinks the company will deliver sustained membership and revenue growth in 2015. It kept a Buy rating on the stock. PRICE ACTION: Aetna shares are up approximately 17% since the company's last earnings report on February 3 and are down over 1% in afternoon trading ahead of Tuesday morning's earnings.
08:04 EDTCNCCentene appoint Ken Yamaguchi to EVP and Chief Medical Officer
Centene announced the appointment of Ken Yamaguchi to Executive Vice President and Chief Medical Officer, effective immediately. Yamaguchi currently is the Sam & Marilyn Fox Distinguished Professor of Orthopaedic Surgery at Washington University and will continue in that role as part-time faculty. Centene also announced the appointment of Mary Mason to Senior Vice President and Chief Medical Officer of Specialty Companies.
April 17, 2015
08:04 EDTCNCCentene's Nurtur receives full URAC accreditation
Centene announced that Nurtur, its health and wellness subsidiary, received full Disease Management Accreditation from URAC, a Washington, DC-based healthcare accrediting organization that establishes quality standards for the healthcare industry.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use